RIPPLE XRP PRICE PREDICTION 2025
1 extracted signal · 1 resolved · 0 still active
Cilinix Crypto01 Oct 2025, 12:34 UTC
AI-generated source summary
The analyst provides a technical analysis for XRPUSDT and XRPBTC. For XRPUSDT, the analyst notes that recent price action has been relatively stable, with a pullback into the upper fair value gap around $2.82. There is still a fair value gap to the downside toward $2.79, so a drop to $2.80 is still possible. Leverage is increasing slightly. Structurally it was important to reclaim $2.8, and that level is currently being held. With new ETF application processes in the United States, an XRP ETF could come sooner. With reclaiming back into the trading range analysts expects a move into $2.92 to $2.95 levels and move into $3 in near term, expecting test of $2.8. Regarding XRPBTC, the analyst mentions it is nearing a major support level and could possibly outperform Bitcoin slightly.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Cilinix Crypto
BREAKDOWN UPDATE: WILL CRYPTO CRASH LOWER?🚨
DON'T MISS THIS MAJOR BULLISH SIGNAL!🔥 (Polkadot Update)
HEDERA PRICE PREDICTION FOR AUGUST! (HBAR Update)
SOLANA BREAKDOWN WARNING NOW!🚨 (SOL Update)
I AM WAITING FOR THIS ETHEREUM MOVE! (ETH Update)
CRITICAL MOMENT FOR XRP! (Breakdown Risk)
Cilinix Crypto
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
